Focus on increasing throughput of processes has favoured poorer models with lower chances of success
The search for new medicines is becoming unsustainably expensive despite huge technological advances because researchers are using the wrong methods, experts say.
They say drug discovery should focus on ‘validity’ – how well the results of experiments predict results in sick people. Instead, it has focused on methods that are easy to industrialize or methods that are academically fashionable.
In a report published in the journal PLOS ONE, Jack Scannell, from Oxford University’s Centre for the Advancement of Sustainable Medical Innovation, and consultant Jim Bosley approach drug discovery using mathematical tools that are used by economists to study decision making. They show that the chance of discovering an effective drug is surprisingly sensitive to the validity of the experimental methods. Small changes in validity can have a bigger effect than running 10 or even 100 times more experiments.
They argue that productivity has declined because the most predictive methods lead to the discovery of good drugs, and research in those areas stops (e.g., stomach ulcers). This leaves scientists working on as-yet-untreated diseases using less predictive discovery methods (e.g., Alzheimer’s). They also suggest that changing industrial and scientific fashions have contributed to the problem.
The result: Methods have become less predictive over time, worse decisions have been made, and the cost of discovery has gone up.
Drug approvals have increased since 2012. The researchers say that this is likely down to the rising use of genetic information which improves the validity of the methods to discover treatments for rare diseases, though less so for common diseases.
Dr Jack Scannell said: ‘There is a nasty puzzle at the heart of modern biomedical research. On one hand, the technologies that people think are important have become hundreds, thousands, or even billions of times cheaper. On the other hand, it costs nearly 100 times more to bring a drug to market today than it did in 1950. New drugs can be very expensive, yet the industry is closing labs and firing scientists. Our work goes some way towards explaining the puzzle. Governments, companies, and charities should focus on identifying and funding predictive methods, even if they don’t match current scientific fashion.’
The Latest on: Drug development crisis
via Google News
The Latest on: Drug development crisis
- NYC Drug Arrests Are Still Costing Millions As Residents Beg For Aid, And Freedom For City Familieson June 27, 2020 at 8:35 am
A new brief from drug reform advocates reveals that New York City remains a hotbed for low-level drug and 'broken windows' arrests of mostly Black and Brown residents, at enormous expense to all.
- Zulu: Alcohol and drug abuse linked to gender-based violenceon June 27, 2020 at 6:40 am
Social Development Minister Lindiwe Zulu has called on all South Africans to join hands in the fight against the scourge of Gender-Based Violence ...
- Mama June and Geno Detail $150,000 Cocaine Habit on 'Family Crisis' Finaleon June 26, 2020 at 7:31 pm
Family Crisis" ended on a somewhat uplifting note, after Mama June Shannon and Geno Doak successfully completed a 30-day stint in rehab. But it wasn't easy, as the two of them detailed just how bad ...
- UAE- COVID-19 crisis and economic downturn threaten to compound drug dangers further still, warns World Drug Report 2020on June 26, 2020 at 1:08 pm
"The COVID-19 crisis and economic downturn threaten to compound drug dangers further still ... so we can achieve the Sustainable Development Goals, promote justice and leave no one behind ...
- Virtual clinical trials now being used to fast-track drug development during coronavirus crisison June 25, 2020 at 5:51 am
Eager to streamline the process of drug development during the pandemic, researchers, pharmaceutical companies and a handful of tech start-ups have started virtual clinical trials, also known as ...
- Trump Administration Empowers Rural Communities with New Resource to Combat Drug Addictionon June 24, 2020 at 12:39 pm
With resources from 16 different Federal departments and agencies, the Rural Community Toolbox is a one-stop shop for those seeking help in building strong healthy, and drug-free rural communities. In ...
- Dan Fumano: Supervised inhalation site delayed, even as COVID worsens overdose crisison June 24, 2020 at 8:40 am
Measures intended to keep people safe during the COVID-19 pandemic might have contributed to more people dying from drug overdoses, B.C.’s longer-running, less-publicized and far deadlier health ...
- A new cancer drug might stop tumors in their trackson June 23, 2020 at 8:19 pm
A new type of cancer drug has shown promising results in Phase 1 trials after preventing tumor growth in more than half of patients who did not have access to any other treatment. Called ...
- The FBI called a powerful opioid developed for the military a public threat. The company selling the drug says it'll save lives.on June 21, 2020 at 2:07 am
Dsuvia, a relative of fentanyl that is 1,000 times stronger than morphine, was funded by the Defense Department and approved by the FDA. But some, including the FBI, say it could exacerbate the nation ...
- A new opioid developed for the Pentagon could fill drug shortages wrought by the coronavirus — but the FBI says it’s dangerouson June 21, 2020 at 2:02 am
There’s a highly potent opioid on the market that you’ve likely never heard of: Dsuvia. This new drug, said to be upwards of 1,000 times more powerful than morphine, was developed with major funding ...
via Bing News